The rare story of Sonia and Eric: pioneers by force and by love

A scientific adventure whose ingredients include the looming threat of a fatal disease, the decision to reinvent themselves as biologists, and the goal of silencing prions.

The clinical trial with antisense oligonucleotides, born of their efforts, is considered one of the most interesting trials of 2025, but this is only a part of the story. This married couple is also pursuing other avenues to halt the onset of prion diseases. In the summer of 2024, they published a study in Science using epigenetic editing in mice. Then, in January 2025, their experiments with base editing were published in Nature Medicine. Yet Sonia Vallabh was a newly graduated jurist, and her husband, Eric Minikel, was working in urban planning, when they discovered that she carried a mutation that would condemn her to die of fatal familial insomnia within two or three decades.

Continue reading

From antisense to CRISPR. Q&A with Ed Wild

ed wild

Dr Ed Wild at the Vatican with co-discoverer of the HD gene – Nancy Wexler

Ed Wild of University College London is a leading scientist and the international coordinator (with Sarah Tabrizi) in a very promising trial using antisense oligonucleotide technology in Huntington patients. This is the interview he gave me before attending the Huntington’s Days 2018 meeting in Turin, Italy.  Continue reading